Works matching DE "SUPERNUS Pharmaceuticals Inc."

SUPERNUS PHARMACEUTICALS INITIATES PHASE IIA CLINICAL TRIAL FOR SPN810 IN CONDUCT DISORDER.

Published in:

Psychiatry (1550-5952), 2009, v. 6, n. 2, p. 15

Publication type:

Article